Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Edralbrutinib |
| Trade Name | |
| Synonyms | TG-1701|TG 1701|TG1701|EBI-1459|EBI1459|EBI 1459|SHR 1459|SHR1459 |
| Drug Descriptions |
Edralbrutinib (TG-1701) is a second-generation irreversible BTK inhibitor, which may result in decreased downstream signaling and reduced tumor growth (PMID: 34551904). |
| DrugClasses | BTK inhibitor 38 |
| CAS Registry Number | 1858206-58-2 |
| NCIT ID | C175775 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Edralbrutinib | Edralbrutinib | 0 | 1 |
| Edralbrutinib + Ublituximab + Umbralisib | Edralbrutinib Ublituximab Umbralisib | 0 | 1 |